| P50 | author | Melissa P DelBello | Q91939875 |
| P2093 | author name string | Jeffrey A Welge | |
| | Robert K McNamara | |
| | Jeffrey R Strawn | |
| | Thomas J Blom | |
| | L Rodrigo Patino | |
| | Max J Tallman | |
| P2860 | cites work | Estimation of metabolite concentrations from localized in vivo proton NMR spectra | Q72319396 |
| | Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T | Q72376930 |
| | Prodromal symptoms before onset of manic-depressive disorder suggested by first hospital admission histories | Q73063968 |
| | Standardization of the PFA-100(R) platelet function test in 105 mmol/l buffered citrate: effect of gender, smoking, and oral contraceptives | Q73079802 |
| | Rapid incorporation of docosahexaenoic acid from dietary sources into brain microsomal, synaptosomal and mitochondrial membranes in adult mice | Q73669639 |
| | A Double-Blind Placebo-Controlled Trial of Omega-3 Fatty Acids as a Monotherapy for Adolescent Depression | Q89473280 |
| | Efficacy and Tolerability of Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis | Q91502993 |
| | Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression | Q22305455 |
| | Omega-3 fatty acids for depression in adults | Q24187951 |
| | A children's global assessment scale (CGAS) | Q28271291 |
| | A rating scale for mania: reliability, validity and sensitivity | Q29619299 |
| | In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time | Q30577367 |
| | Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements | Q31050854 |
| | Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials | Q33578486 |
| | Psychotropic medication exposure and age at onset of bipolar disorder in offspring of parents with bipolar disorder | Q33714517 |
| | Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections. | Q33943502 |
| | Cross-national comparisons of seafood consumption and rates of bipolar disorders | Q33974158 |
| | Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression | Q34014195 |
| | Type and duration of subsyndromal symptoms in youth with bipolar I disorder prior to their first manic episode | Q34294725 |
| | Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis | Q34352492 |
| | Automatic, localized in vivo adjustment of all first- and second-order shim coils | Q34352735 |
| | Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study | Q34468355 |
| | Review of studies of child and adolescent offspring of bipolar parents | Q34530094 |
| | Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety | Q34869621 |
| | Diagnostic Precursors to Bipolar Disorder in Offspring of Parents With Bipolar Disorder: A Longitudinal Study | Q35811945 |
| | Glutamatergic effects of divalproex in adolescents with mania: a proton magnetic resonance spectroscopy study. | Q35843375 |
| | Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review | Q35909656 |
| | Relation between red blood cell omega-3 fatty acid index and bleeding during acute myocardial infarction | Q36081403 |
| | A systematic review and meta-analysis of prospective transition from major depression to bipolar disorder | Q36252218 |
| | Frontal lobe bioenergetic metabolism in depressed adolescents with bipolar disorder: a phosphorus-31 magnetic resonance spectroscopy study | Q36295874 |
| | First-episode bipolar disorder is associated with erythrocyte membrane docosahexaenoic acid deficits: Dissociation from clinical response to lithium or quetiapine | Q36305068 |
| | A Randomized Controlled Trial of Individual Family Psychoeducational Psychotherapy and Omega-3 Fatty Acids in Youth with Subsyndromal Bipolar Disorder. | Q36405769 |
| | Adolescents with or at ultra-high risk for bipolar disorder exhibit erythrocyte docosahexaenoic acid and eicosapentaenoic acid deficits: a candidate prodromal risk biomarker. | Q36759325 |
| | Expert opinion: omega-3 fatty acids and bleeding-cause for concern? | Q36763078 |
| | Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. | Q36915538 |
| | Meta-analysis of erythrocyte polyunsaturated fatty acid biostatus in bipolar disorder | Q36940652 |
| | A comprehensive review and model of putative prodromal features of bipolar affective disorder. | Q36941947 |
| | Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function | Q37412199 |
| | Symptoms and signs of the initial prodrome of bipolar disorder: a systematic review | Q37626234 |
| | Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study. | Q37712537 |
| | Detection and Treatment of Long-Chain Omega-3 Fatty Acid Deficiency in Adolescents with SSRI-Resistant Major Depressive Disorder. | Q37720606 |
| | A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression | Q37746266 |
| | A depression rating scale for children | Q38556347 |
| | Dietary n-3 PUFA, fish consumption and depression: A systematic review and meta-analysis of observational studies | Q38932759 |
| | Dietary patterns and depression risk: A meta-analysis | Q39255050 |
| | A pilot pharmacotherapy trial for depressed youths at high genetic risk for bipolarity | Q40016044 |
| | The predictive validity of bipolar at-risk (prodromal) criteria in help-seeking adolescents and young adults: a prospective study | Q40189055 |
| | Differential modulation of the glutamate transporters GLT1, GLAST and EAAC1 by docosahexaenoic acid | Q40445306 |
| | Emulsified omega-3 fatty-acids modulate the symptoms of depressive disorder in children and adolescents: a pilot study. | Q40963212 |
| | Choline in pediatric depression. | Q42134296 |
| | Inhibition of astroglial glutamate transport by polyunsaturated fatty acids: evidence for a signalling role of docosahexaenoic acid | Q42453489 |
| | n-3 PUFA status affects expression of genes involved in neuroenergetics differently in the fronto-parietal cortex compared to the CA1 area of the hippocampus: effect of rest and neuronal activation in the rat. | Q42506215 |
| | Role of monoaminergic system in the etiology of olive oil induced antidepressant and anxiolytic effects in rats | Q43070876 |
| | Omega-3 fatty acids deprivation affects ontogeny of glutamatergic synapses in rats: relevance for behavior alterations | Q43155661 |
| | A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder. | Q43699931 |
| | Associations between central and peripheral measures of phospholipid breakdown revealed by cerebral 31-phosphorus magnetic resonance spectroscopy and fatty acid composition of erythrocyte membranes. | Q43772382 |
| | Proton magnetic resonance spectroscopic imaging in pediatric major depression | Q44061643 |
| | International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis | Q44880962 |
| | Increased parental history of bipolar disorder in the United States: association with early age of onset | Q44962068 |
| | Age effects on antidepressant-induced manic conversion | Q45003904 |
| | Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. | Q46155653 |
| | A pilot study of antidepressant-induced mania in pediatric bipolar disorder: Characteristics, risk factors, and the serotonin transporter gene | Q46301946 |
| | Correlation between choline signal intensity and acetylcholine level in different brain regions of rat. | Q46947003 |
| | Multigenerational Positive Family History of Psychiatric Disorders Is Associated With a Poor Prognosis in Bipolar Disorder | Q46948351 |
| | Antidepressant exposure in bipolar children | Q47204446 |
| | Omega-3 supplementation associated with improved parent-rated executive function in youth with mood disorders: secondary analyses of the omega 3 and therapy (OATS) trials. | Q47235837 |
| | Individual and familial risk factors for bipolar affective disorders in Denmark | Q47334174 |
| | Fish consumption and major depression | Q47757469 |
| | Antidepressant tolerability in anxious and depressed youth at high risk for bipolar disorder: a prospective naturalistic treatment study. | Q47990576 |
| | Glutamate homeostasis in the adult rat prefrontal cortex is altered by cortical docosahexaenoic acid accrual during adolescence: An in vivo1H MRS study | Q48011520 |
| | Pilot Randomized Controlled Trial of Omega-3 and Individual-Family Psychoeducational Psychotherapy for Children and Adolescents With Depression. | Q48036852 |
| | Psychoeducational Psychotherapy and Omega-3 Supplementation Improve Co-Occurring Behavioral Problems in Youth with Depression: Results from a Pilot RCT. | Q48041573 |
| | A Longitudinal (6-week) 3T (1)H-MRS Study on the Effects of Lithium Treatment on Anterior Cingulate Cortex Metabolites in Bipolar Depression | Q48073482 |
| | Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: observations from 160,000 patients. | Q50495766 |
| | Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial. | Q50707428 |
| | A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. | Q50924850 |
| | Safety and tolerability of prescription omega-3 fatty acids: A systematic review and meta-analysis of randomized controlled trials. | Q51246512 |
| | Adolescents' self-assessment of sexual maturation. | Q52296263 |
| | Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. | Q55042041 |
| | Multigenerational transmission of liability to psychiatric illness in offspring of parents with bipolar disorder | Q56535598 |
| | Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies | Q57471889 |
| | High contrast and fast three-dimensional magnetic resonance imaging at high fields | Q63894361 |
| | Bipolar illness in adolescents with major depression: clinical, genetic, and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation | Q70392247 |
| | Use of the Children's Depression Rating Scale in an inpatient psychiatric population | Q71741014 |
| P921 | main subject | placebo | Q269829 |
| | neurochemistry | Q786278 |
| | fish oil | Q1786125 |
| | bipolar I disorder | Q4915474 |
| P577 | publication date | 2020-03-11 | |
| P1433 | published in | Journal of Child and Adolescent Psychopharmacology | Q15756086 |
| P1476 | title | Effects of Fish Oil Monotherapy on Depression and Prefrontal Neurochemistry in Adolescents at High Risk for Bipolar I Disorder: A 12-Week Placebo-Controlled Proton Magnetic Resonance Spectroscopy Trial | |